2026 Poster Presentations
Preliminary List as of 29 October. 350+ posters are expected, so please check back.
2bind GmbH
A Screening Platform to Find a Cure for Ebola
A*STAR, Singapore Immunology Network
Overcoming Solid Tumor Heterogeneity with Car T Cells Secreting Anti-EpCAM Bi-Specific T Cell Engagers
AAX Biotech AB
Opti-mAb®: A Novel scFv Format for Improved Therapies
Ability Biotherapeutics
Generative Design of pH-Sensing Antibodies for T Cell Engagers: Mesothelin and CD3e
AbTherx
A New and Differentiated Transgenic Platform for Rapid Generation of Developable Human Therapeutic Antibodies
Abvion Biologics B.V.
Direct Proteomic Discovery of Circulating Antibodies Yields Potent Neutralizers Overlooked by BCR Sequencing
ACROBiosystems
Integrated Strategies for Producing Functional Recombinant Proteins to Advance Autoimmune Disease Therapeutics
Adimab LLC
A Comprehensive Developability Panel for Accelerating Antibody Development into the Clinic with a Selective and Highly Predictive Set of Assays
Adimab LLC
Predicting Biophysical Properties of Multispecific Antibodies
Adocia
Stable Co-Formulation of Cagrilintide and Semaglutide Enabled by the BioChaperone® Technology for Multi-Dose Pen Injectors
Agilent Technologies
Complementary Methodologies for Analysis of NIST mAb Impurities Using Agilent LC and CE Systems
Agilent Technologies
Comprehensive Analysis of Monoclonal Antibodies and Antibody-Drug Conjugates Across Multiple Analytical Levels
Ajinomoto Bio-Pharma Services
Expanding the Potential of Antibody Conjugates: AJICAP® Technology for Versatile DAR Control and Novel Modality Applications
Ajinomoto Co., Inc.
Advancing VHH Therapeutics with Corynex™: Precise Conjugation and Extended Half-Life
Ajinomoto Co., Inc. and Imperial College London
De Novo Design of Mini-Proteins as Specific Binders to PACAP-38, a Key Mediator of Migraine
Ajou University
Engineering Human Hyaluronidase PH20 for Enhanced Thermostability and Catalytic Activity Improves Functional Pharmacokinetics and Therapeutic Efficacy
Ajou University
NKG2D Ligand Affinity Governs the Antitumor Potency of EGFR-Targeted NK Cell Engagers
Alaya.bio
Targeting Polymeric Gene Delivery Platform for T Cell Reprogramming
Alcyomics Ltd.
Skimune®: A Powerful Human-Centric Platform for the Identification of T Cell Engager Immunotoxicity
Alloy Therapeutics
High Velocity Approach to Antibody Discovery and Optimization Using AI-Enabled and ML-Powered In Silico Workflows Combined with High-Throughput Expression and Testing
Almac Discovery Ltd.
A Next-Generation Bispecific ADC Platform for Enhanced Solid Tumour Therapy and the Treatment of Drug-Resistant Cancers
Amgen, Inc. and LUMICKS
Towards Validation of Cell Avidity as a Critical Assay for Improving Human Dose–response Prediction and Preclinical Screening of T-Cell Engagers Therapies
Apoha
A Format-Independent, Coalescence-Based Physical Readout for Developability, Formulation and Predictive Models
Apoha
Sequence Attribution of a Clinically Thresholded Developability Risk Measure for Antibodies
Araris Biotech AGa
ARC-401, a Triple Payload First-in-Class ADC Against Nectin-4 Designed to Overcome Cancer Resistance and Tumor Heterogeneity, Shows Broad Anti-Tumor Activity and High Tolerability in Relevant Animal Models
Asimov
Engineering Precision with CHO Edge: A Framework for Producing Complex Multispecific and Difficult-to-Express Proteins
AstraZeneca
A Next-Generation Rabbit B Cell Antibody Platform
AstraZeneca
Automated Large-Scale Biologics Expression Platform
AstraZeneca
Diversity that Delivers: Structurally Designed Libraries Powering Peptide Binder Discovery
AstraZeneca
From In Silico to In Solution: An Integrated Structural Biophysics Workflow for Biologics Developability
AstraZeneca
Integrating Structural Biology and Biophysical Characterisation to Accelerate Drug Discovery
AstraZeneca
Next-Generation Antibody–Drug Conjugates: High Drug Loading and Multiple Payloads
Athebio AG
Unlocking Precision: The Versatility of the Athebody Platform for Targeted Therapeutics
Avenue Biosciences
High-Throughput Signal Peptide Engineering for Higher Titers and Better Manufacturability Across Protein Modalities
AVS Bio
Amplifying the Therapeutic Potential of Rabbit-Derived Antibodies by an Advanced, Multi-Parametric Humanization Approach for Single-Step Engineering
AVS Bio
Boosting Diversity-Focused Lead Antibody Generation by In Silico-Guided Rare Hit Magnification and Epitope-Driven Affinity Finetuning
Axxam S.p.A.
An Integrated Workflow for Accelerated VHH Identification and Characterization with High-Throughput Functional Assays: A Comprehensive Case Study on CDK2/CycE1 Complex
Beckman Coulter
Automated Cell Handling and Lipofection-Based Transient Transfection Design of Experiments (DOE) on the New Biomek i3 Benchtop Liquid Handler
Beckman Coulter
Rapid, High-Throughput IgG Quantification in Crude Cell Culture Samples
Beckman Coulter
SV-AUC Characterization of Peptides: A Case Study with Semaglutide
BioCopy AG
Peptide-Centric Interface Topology Distinguishes Selective MAGE-A4 Directed TCR-Mimic Antibodies
BioCopy AG
Validate®: Proteome-Wide Off-Target De-Risking of HLA-A02:01 MAGE-A4 TCR-Mimic Antibodies
BioCopy AG
ValidaTe®-Guided Discovery of a Potential Best-in-Class MAGE-A4/HLA-A02:01 (GVY) Directed TCRm-Based T-Cell Engager with Superior Specificity
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
BCG015: A First-in-Class Antibody-Drug Conjugate Targeting TM4SF5 for the Treatment of Hepatocellular Carcinoma
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
CRB2104: A 2:1 AMHR2/CD3 T Cell Engager Targeting AMHR2-Positive Solid Tumors
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Novel Blood-Brain Barrier Penetrating Heavy Chain-Only Antibodies Targeting CD98
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
RenSuper Workstation™: An AI-Powered, Closed-Loop In Vivo Discovery and Automation Engine for High-Efficiency Therapeutic Antibody Generation Infrastructure
Biofidus AG
Comprehensive Multi-Omics and Functional Profiling Gives Insights into Mechanisms Driving Resistance to Antibody-Drug Conjugates
BioInnovation Institute Foundation
Engineering pH-Responsive Antibodies Through Framework-Guided Design: A Universal Platform for Antibody Recycling and Enhanced Biologic Performance
Biointron
AbDrop™ Speeds: Accelerating Your Antibody Discovery with Single B Solution
Bioneer
3D BioSPHEER™ Models for Functional Evaluation of Cancer Therapies
Bioneer
Bio1Run Methodology: Accelerating Production Mode Decision-Making
Bio-Rad Laboratories
Accelerating Anti-Biotherapeutic Tool Antibody Development with Bio-Rad's Pioneer Select Platform
Bio-Rad Laboratories
Generation of Fc-Mutation Specific Antibodies Using Phage Display
Bio-Rad Laboratories
Rapid Lead Generation with the Pioneer Antibody Discovery Platform
Bioworkshops
Upstream Glycoengineering Approach to Control N-Glycan Profiles of Fc-Mediated ADCC/CDC Biosimilars
Boehringer Ingelheim Pharma GmbH & Co. KG
End-to-End Automation Enables 10-Fold Expansion of Early-Phase Formulation Design Space Exploration
Boehringer Ingelheim Pharma GmbH & Co. KG
Viscosity Prediction of High-Concentration Antibody Solutions from All-Atom MD Simulations
BOKU - University of Natural Resources and Life Sciences
REM-BAC - A Scalable Path to Precision Engineered Producer Cell Lines
BOKU - University of Natural Resources and Life Sciences
Understanding the Influence of Protein Surface Mutations on Expressibility: Variant Library Analysis with Explainable AI
Boldrini Research Center
A Humanized NBSGW Mouse Platform for In Vivo Evaluation of a Humanized Anti-IL-7Ralpha Antibody in Pediatric Leukemia
Botnar Institute of Immune Engineering (BIIE)
Data Generation for Immune Receptor Specificity Models
Bruker Cellular Analysis
Single-Cell Function Driven Screening and Characterization of Bispecific T Cell Engagers
Bruker Dynamic Biosensors
Integrated Biophysical Analysis of Fc–FcR Binding, Affinity, and Avidity in Antibody Therapeutics
Carterra, Inc.
Accelerating the Discovery of Therapeutic Antibodies Using High Throughput SPR
Carterra, Inc.
Strategies for Scalable and Sensitive Determination of High Affinity and Slow Dissociating Binding Interaction Kinetics in Antibody Discovery
CEA - French Alternative Energies and Atomic Energy Commission
Engineering Orthogonal CH3 Interfaces for Enhanced Bispecific Antibody Production
Cellmover AS
CM101: A Cell-Penetrating VHH for Intracellular Immune Checkpoint Inhibition
Center of Molecular Immunology, Cuba
Mapping the Fine Specificity of Anti-SARS-CoV-2 RBD Antibodies Combining Phage Display and Next Generation Sequencing
Center of Molecular Immunology, Cuba
Structural Bases of Beta-Chain-Biased Interleukin-2 Variants’ Superagonism: Insights from Enhanced-Sampling Simulations
Centre National de la Recherche Scientifique (CNRS)
Identification of the Molecular Interface Between the Envelope and Capsid Proteins in Hepatitis B Virus
Chemical Computing Group
Pharmacophore-Guided Virtual Screening of Antibody Formats
Chemical Computing Group
Structure-Based Charge Calculations for Predicting Properties and Profiling Antibody Therapeutics
CLADE GmbH
FT-IR-Based Multi-Attribute Approach for Quantification of APIs and Excipients in Coformulations
Concordia University
Active-Learning Design of Peptide Binders to Bacterial Endotoxin LPS, Scored with Umbrella Sampling
Constructive Bio
Reprogramming the Genetic Code for the Recombinant Production of Next-Gen Biotherapeutics
Coriolis Pharma Research GmbH
To Platform or Not to Platform: Using the ReFOLD Assay and Formulation Sensitivity to Guide Early Development
Creative Biolabs, Inc.
A Robust and Comprehensive Development Framework for Antibody-Oligonucleotide Conjugates (AOCs)
Creative Biolabs, Inc.
Safety and Efficacy of Bispecific and Multispecific Antibodies
Cube Biotech GmbH
PlateX MP™: Automated Full-Length Membrane Protein Preparation for Ligand Screening and Hit-to-Target Identification
Deeptope
Antibody Optimization Case Studies by Deep Mutational Scanning
Deeptope
Epitope Mapping Case Studies by Deep Mutational Scanning
Diamond Light Source Ltd.
A Roadmap for Systematic Discovery of Novel Binding Pockets via Macromolecular Crystallography and QMMM
DIMA Biotechnology
The Application of Nanodisc Technology Platform to Develop Therapeutic mAbs for Multi-Pass Transmembrane Protein Targets
Discovery Evolution
Mapping GPCR States to Guide State-Selective Antibody Design
Discovery Evolution
RedQueen: Digital Directed Evolution of Antibody Paratopes for Challenging GPCR Targets
Elephas Biosciences
Functional Profiling of TME-Dependent Immunotherapies in Live Human Tumour Fragments
EPFL - Swiss Federal Technology Institute of Lausanne
Computational Design of Functional Nanobodies for G-Protein Coupled Receptors
Epsilogen Ltd.
IgE: Ultra-High Efficacy for Ultra-Low Antigen Tumours
ESQlabs GmbH
Beyond mAbs: A PBPK Biodistribution Model Spanning scFv, F(ab), Nanobodies, Affibodies and More
ETH Zurich
Functional Mapping of the Local TCRab Specificity Landscape
evitria AG
Overcoming scFv Instability in Complex Multispecific Formats with Opti-mAb®
ExpreS2ion Biotechnologies
Engineering the Drosophila S2 Platform: From Complex Protein Expression to Phase III Clinical Manufacturing
FairJourney Biologics
Driving Antibody Optimization with Broad-Space and Structure Guided Platforms: Tumbler™ and Targeted Engineering
FairJourney Biologics
Enabling Bispecific Antibody Development Through Integrated Discovery and Humanization
FairJourney Biologics
Functional Tailoring: A Sensitive Reporter Cell Line for Screening of Agonistic Anti-OX40 Antibodies from Single B-Cell Campaigns
FairJourney Biologics
Mastering the Molecule: Bioconjugation and In-Depth Characterization Strategies
FUJIFILM Wako Pure Chemical Corporation
A Platform for Generating Rabbit Monoclonal Antibodies Against Membrane Proteins Using Antigen-Loaded Extracellular Vesicles
Fusion Antibodies
OptiMAL®: Mammalian Display for Antibody Discovery
Genedata AG
A Digital Platform for the Development of Next-Generation Antibody Drug Conjugates (ADCs) and Other Antigen-Targeting Conjugates
Genedata AG
An Automated High Throughput Engineering Platform for AI-Supported Developability Predictions
Genedata AG
Ensuring Data Quality, Traceability, and Interpretability with Automated Assay Data Workflows
Genedata AG
In-Depth Characterization of Antibody-Drug Conjugates by Subunit-Level Mass Spectrometry
Genedata AG
Smart Analysis of Experimental Context and Accelerated Biologics Lead Optimization Through AI-Guided Developability Workflows in Hit Profiler
Genentech, Inc.
Brightfield-Only AI Readouts for T-Cell Killing Assays: Label-Free, Segmentation-Free Hit Calling
GENEWIZ from Azenta Life Sciences
Accelerating Antibody Discovery: High-Throughput Solutions for Producing Antibodies at Scale
GENEWIZ from Azenta Life Sciences
Leveraging High-Throughput Platforms for the Discovery of Bispecific Antibodies
Genovis AB
Pan-Immunoglobulin Capture and Native-State Antigen Release Using AlligBAITOR™
Genovis AB
Performance Characterization of a Recombinant Protease Platform for Bottom-Up Proteomics
GenScript
4-Day Sequence-to-Data: Accelerating AI-Driven Protein Discovery via Integrated Cell-Free Workflow
GenScript
Accelerate the Design-to-Data: Scalable Purification Automation for AI-Driven Biologics Discovery
GenScript / ProBio
Utilization of Naïve VHH Phage Display Library and Integrated Antibody Engineering Platform to Generate Antibody Leads for CAR-T Therapy
Helmholtz Centre for Infection Research
Production and Purification of Virus-Like-Particles in HighFive Cells for Various Applications
iBET - Instituto de Biologia Experimental e Tecnológica
Cognate Chain Expression Imbalance: A Key Driver of Bispecific Antibody Mispairing in CHO Cells
Icosagen Cell Factory OÜ
Discovery of Functional Antibodies Against Challenging Membrane Protein Targets
Immunocore Ltd.
Improving the Developability Profile of ImmTAV Molecules Targeting HIV Infected Cells
Imperial College London
Multi-task learning for predicting peptide developability properties
Indian Institute of Technology, Madras
Pep_Dez: An AI-Guided Active Learning Framework for the Rapid Design of De Novo Peptide Disruptors of Protein-Protein Interactions
InSCREENeX GmbH
Universal Landing Pad Technology for Highly Efficient Cell Line Engineering
Institut de Recherche en Cancérologie de Montpellier (IRCM)
Assessment of Individual Antibody Thermal Stability Within a Pool by Phage Display and Next-Generation Sequencing
Institute of Cancer Research
MRC2 Antibody-Drug Conjugate Targeting Cancer-Associated Fibroblasts
Institute of Cancer Research
Targeting Solid Tumours with MRC2 CAR-T Cells
Instituto Butantan
Optimization and Biophysical Characterization of Site-Specific PEGylation of Recombinant FabC11 for Shiga Toxin 2 Neutralization
Integral Molecular
Antibodies Against 100+ Impossible Protein Targets: High-Quality mAbs for Previously Intractable GPCRs, Ion Channels and Transporters
Integral Molecular
Engineering GPRC5D Multispecific Antibodies: Parallel Engineering to Optimize Affinity, Developability, Species Reactivity, and IP
Integral Molecular
How Specific Are Antibody Therapeutics?: A Systematic Evaluation of Drugs Throughout Preclinical and Clinical Development
Integrated DNA Technologies a Danaher Company
Diverse Library Generation Using IDT oPools and Synthetic Biology Custom Solutions
International Centre for Genetic Engineering & Biotechnology (ICGEB)
Development of Novel Anti-Malarial Monoclonal Antibodies Against Plasmodium falciparum
iOmx Therapeutics AG
From Target to In Vivo: Seamless AI/ML and Wet Lab Integration in T Cell Engager Discovery
IQVIA Laboratories
De-Risking Biotherapeutics with Human-Relevant NAMs Safety Platform
Jackson Laboratory
A Comparison of Preclinical Models for PK Allometric Scaling of Antibodies
Jackson Laboratory
A Humanized FcRn x Albumin Model to Assess HSA-Fused Therapeutic Candidates and FcRn Antagonists
KACTUS
The Native Edge: KACTUS CD3 VLPs and Nanodiscs for Precision T-Cell Therapy and Discovery
KACTUS
Unlocking the Complete KLK Family: Active-Form, Multi-Species and Ultra-Pure
Kaneka Eurogentec SA
A Versatile Microbial Platform for Rapid GMP Manufacturing of VHH Antibodies
Kaohsiung Medical University
A Membrane-Tethered Chromogenic Enzyme System for Efficiently Monitoring Gene Expression
Kaohsiung Medical University
Combination of Lenalidomide and Dexamethasone with Pro-Anti-PD-1 Antibodies for Enhanced Safety and Efficacy in Multiple Myeloma Therapy
Kaohsiung Medical University
Innovative Antithrombotic and Cardiovascular Disease Therapeutic Strategy Through Development of a Specific Anti-PAR4 Monoclonal Antibody
Kaohsiung Medical University
Targeting PEGylated Asparaginase (PEG-ASNase) to B Cell Lymphoma with Bispecific Antibody (CD20 Ab × mPEG scFv) to Enhance Anti-Tumor Activity
Kaosiung Medical University
In Silico Engineering a Caninized Anti-CD20 Antibody for Safer and More Effective Canine Lymphoma Immunotherapy
KBI Biopharma
Accelerating Cell Line Development Through Robust Selection Strategies And Automation
KBIOHealth - OSONG Medical Innovation Foundation
Development of a Novel Polypeptide- Based IDP tag for Long-Acting Biologics
KBIOHealth - OSONG Medical Innovation Foundation
Development of an AI-Powered Antibody and Protein Design Platform
Kimialys
Toward True Sub-nM Affinity Readouts of Antibodies in SPR with K-One Surface Chemistry
Kling Biotherapeutics
Natural Antibody Evolution, Human Expertise, and AI: The MAb-Intelligence Triad for Next-Generation Antibody Discovery
Kookmin University
Development of a Novel CD3e-Specific Human Antibody for Selective Modulation of T Cell Activation
Kookmin University
Functional Epitope Mapping of Cell Surface Glucose-Regulated Protein 94: A Combinatorial Approach for Therapeutic Targeting
Kookmin University
Intrabody Targeting of Insulin Receptor pY1150: A Novel Approach to Modulate Signaling Pathways in Colorectal Cancer Cells
Kookmin University
Molecular Basis of CD155-Mediated Immune Regulation Revealed by a Novel Epitope-Specific Human Monoclonal Antibody
Kookmin University
Rapid Isolation and Characterization of High-Affinity Single-Domain Antibodies for Broad-Spectrum Detection of SARS-CoV-2 Variants
Korea Advanced Institute of Science & Technology (KAIST)
Development of a Macrophage Mediated Payload Delivery System for Precise Solid Tumors Therapy
Korea Advanced Institute of Science & Technology (KAIST)
Engineering Yeast Metabolism and Heterologous Gene Expression with Rap1 for Enhanced Triterpenoid Saponin Production
Korea Advanced Institute of Science & Technology (KAIST)
RMCE-based genome-wide CRISPR screening to enhance CHO cell fitness under ammonia stress and hypothermia
Korea National Institute of Health
Discovery and Characterization of a Dual-Acting Antiviral Compound Targeting SARS-CoV-2 3CLpro and Host Cathepsin L
Korea National Institute of Health
Preserved Antiviral Efficacy of Approved COVID-19 Therapeutics Against Emerging SARS-CoV-2 Omicron Subvariants
Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Advancing Pancreatic Cancer Therapy by Mesothelin-Specific Nanobody Conjugation
Korea Research Institute of Bioscience and Biotechnology (KRIBB)
CRISPR/Cas12a2 Enables Ultra-Sensitive Amplification-Free RNA Detection
Korea Research Institute of Bioscience and Biotechnology (KRIBB)
De Novo Design of Hyperstable PD-L1 Nanobinders
Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Engineering a Soluble Dimeric Protein Platform in Escherichia coli
Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Enhancement of Collateral Activity Using Engineered CRISPR-Cas12j and Tailored Reporters
Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Impurity Profile-Guided Purification Strategy for Knobs-into-Holes Bispecific Antibodies
Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Targeting the TSLPR Heterodimer Interface: AI-Driven Design of Nanobinders to Suppress Type 2 Inflammatory Signaling
KU Leuven
Engineering Obligatory TIM3xVISTAxCSF1R Tri-Specific Antibody to Unlock TAM Anti-Tumoral Function
KU Leuven
Increasing Brain Half-Life of Antibodies by Additional Binding to Myelin Oligodendrocyte Glycoprotein, a CNS Specific Protein
KU Leuven
Retrofit Platform: Engineering Next-Generation Antibodies Against the Root Causes of Immune Resistance
leadXpro AG
Integrated Membrane Protein Production and Structural Biology for Biologics Discovery
Leanbio
Analytical Similarity Assessment of a Monoclonal Antibody Biosimilar Through Orthogonal Structural and Functional Characterization
LifeArc
Driving Patient Impact Through Therapeutic Antibody Discovery
Lightcast Discovery Ltd.
Envisia: Advancing Antibody Discovery with Function-Focused Profiling at the Single-Cell Level
LiveDrop Bio
Accelerating Therapeutic Antibody Discovery with High-Throughput Droplet Microfluidics
LiveDrop Bio
From iPSCs to Immune Cells: High-Throughput Production and Single-Cell Functional Analysis with Droplet Microfluidics
Lonza
A Sensitive Aqueous-Phase Cytokine Release Assay for Cytokine Storm Risk Assessment of TGN1412 in Human PBMCs
Lonza
Affinity Optimization of Anti-TfR1 VHH Blood-Brain Barrier Crossers for CNS Delivery Applications
Lonza
Demonstration of Lonza’s Intensified Fed-Batch for Multiple Products and Scales
Lonza
GlycoConnect® Dual-Payload ADCs with SYN-duo® CA, Which Combines a Camptothecin and an Auristatin Payload, Demonstrate Enhanced Anti-Tumor Efficacy Compared to Respective Mono-Payload ADCs
Lonza
GS Ori -Go®: Next -Generation CHO Expression Vectors for Enhanced Productivity, Stability and Speed
LUMICKS
Avidion: High-Throughput Cell Binding Avidity Platform for Screening Cell Engagers, Multispecific Antibodies, and Cell Therapies
Lund University
Is Spray-Drying Really That Harsh on Proteins?
Lxbio
LxbioAb End-to-End Antibody Discovery Platform: A Case Study
Mabylon AG
Engineering Multispecific Antibody Therapeutics for Allergy Prevention
MacFarlane Burnet Institute for Medical Research
Two Heads Are Better Than One: Dimeric IgA (dIgA) Bispecifics Raising the Bar in Mucosal Immunity
Mario Negri Institute for Pharmacological Research - IRCCS
From Design to Function: An Integrated Platform for Miniprotein Discovery Targeting Gelsolin
Mario Negri Institute for Pharmacological Research - IRCCS
From Design to Function: Method Optimization of an Integrated Pipeline for Miniprotein Discovery
Masaryk Memorial Cancer Institute
From scFv Phage Library to Anti-GPA33 Antibody Lead: RSE-05 for Claudin 18.2-Negative Oesophageal Adenocarcinoma
Max Planck Institute for Biology
Connectase: Antibody Conjugation Without Compromise
Max Planck Institute for Biology
Connectase: Next Generation Bioconjugation
maxcyte
Advancing the Discovery and Development of Biologics and Next-Generation Immunotherapies through Innovative Expression and Screening Techniques
McGill University
Sequence-Only Antibody Generation Yields a pH-Sensitive, Cross-Reactive Mesothelin Campaign Lead
MiLaboratories
Mapping Antibody Affinity Landscapes from Deep Mutational Scanning
MiLaboratories
Multi-Parametric Lead Prioritization from Terminal Single-Cell B Cell Repertoires
MImAbs SAS
A Fast and Integrated Workflow for the Discovery of Highly Internalized Anti-HER2 ADCs
Mosaic Biosciences, Inc.
Bulk Humanization of Murine and Camelid Antibodies Accelerates Biologics Discovery with Minimal Variants
Nanyang Technological University
Understanding and Engineering PETase Across Temperature, Product Inhibition and PET Crystallinity
National Research Council Canada & Polytechnique Montreal
Designing Coil-Functionalized Antibodies with Preserved Manufacturability for the Generation of Antibody-Drug Conjugates
NBE-Therapeutics AG
Where Does It Go? A Reporter Dye System to Investigate ADC Trafficking and Release Kinetics In Vitro and In Vivo
NEC Bio Therapeutics GmbH
AI-Based Optimisation of Immunogenicity Profile for Biologics
Nexus BioQuest
Beyond Binding: Human Immune Cell Assays for Assessing Antibody Fc Function
Nexus BioQuest
Bridging the Translational Gap: In Vitro Platforms for Assessing Therapeutic Depletion Mechanisms
Nona Biosciences
Developing a Fully Human CD19 T Cell Engager Using Nona HBICE Platform
Nona Biosciences
Fully Human HACb Antibody Discovery Enhanced by Hu-mAtrIx AI-Integrated Platform
Novartis Pharma
Addressing Downstream Bottlenecks in High-Titer Bioprocessing
Novartis Pharma
Optimizing Antigen-Expressing Stable Cell Line Development Using Transposases
Novo Nordisk A/S
FIDA Profiling for Peptide and Miniprotein Screening in Pharmaceutical Development
Novo Nordisk A/S
Prodrug Antibody for Enhanced Tissue Targeting
Novo Nordisk A/S
Towards a Cross-Format Framework for Early Stage VHH Developability Assessment
NovoFy, Inc.
NovoFy - Designing the Inaccessible: Generative Minibinders for Intracellular Targets
nuantic AG
AI-Guided Optimization for Therapeutic Proteins: Computational Variant Generation, Prioritization and Experimental Validation Across Developability, Affinity, and Immunogenicity-Risk Objectives
Nuclera
Cell-Free–Produced Antibodies Match CHO for Binding Assessment
Nuclera
From DNA to Active, Monomeric β1AR Receptor in <72 Hours Using Cell-Free Synthesis
OmniAb
Development of OmniUltra™: A Transgenic Chicken System for the Generation of Ultralong CDRH3 Antibodies, Mini-Proteins, and Structured Peptides
PAIA Biotech GmbH
pH-Dependent FcRn Binding and Release Assay in a Microplate: A New Method for Screening Fc Interactions of mAbs, Bispecifics and Fc Engineered Antibodies
PAIA Biotech GmbH
Predicting PAIA Developability Readouts of Bispecific Antibodies From Monospecific Parentals
Panome Bio
Kinase Activity Decoupled from Expression: Deep Phosphoproteomic and Metabolic Profiling of KRAS-Mutant Colorectal Cancer Cells
Plectonic Logibody GmbH
Same Assay, Stronger Signal: Ultra Beacons – Nanoparticle Signal Amplification for Ultra-Bright Antibodies in High-Sensitivity Assays
Portal Biotech Ltd.
Optimizing the Right Candidates: Live-Cell Validation of Impermeable Peptides and Novel Modality Candidates Prior to MedChem
Portal Biotech Ltd.
Seeing the Whole Story: Richer Molecular Information for Faster Antibody Development
Primrose Bio
The Pfenex Platform for Preclinical VHH-ADC Development
ProImmune, Inc.
Ankyrons® - Next Generation Target Binding and Detection
Promega Corporation
Bioluminescent Assays for Antibody Drug Conjugate Development: Internalization and Bystander Killing Functions
Protein Metrics by Dotmatics
Antibody and Therapeutics Discovery: Validating Multi-Dataset Enrichment Analysis Against a Published Phage Display Campaign
Protein Metrics by Dotmatics
Automated, High-Throughput Screening of Complex Biologics
Protein Metrics by Dotmatics
Progressive Deconvolution Provides Robust Feature Detection and Quantitation for Large Mass Intact MS Analyses
ProteoNic
Boosting CHO Cell Productivity with 2G UNic Vector Technology and Transposon Innovation
ProteoNic
Characterization of Vector Integration of Proteonic 2G UNic® Transposon Technology
QVQ Holding BV
Lead Discovery and Functionalization of Single-Domain Antibodies for Detection and Imaging of G Protein-Coupled Receptors
Refeyn Ltd.
Mass Photometry Reveals Bevacizumab:VEGF Stoichiometry and FcγRIIa Engagement, with Heparin-Dependent Complex Modulation
Rezon Bio
Rapid Screening Disulfide Scrambling Analysis of IgG1 by LC-MS
RIC Biologics
De-Risking Protein Biologics Through Comprehensive Developability Assessment
RIC Biologics
Evaluation of Disulfide Bond Scrambling in Monoclonal Antibodies by Peptide Mapping in Non-Reducing Conditions
RIC Biologics
High-Performance Antigen Affinity Chromatography of Monoclonal Antibodies in One- And Multidimensional Configurations
Roche Glycart AG
An Orthogonal Cis-Targeting Platform for Delivery of Attenuated Cytokines to Chimeric Antigen Receptor T Cells
RoukenBio
An Integrated Human Assay Cascade for ADC Evaluation: From Target Engagement to Complex Tumour Microenvironment Activity
RoukenBio
Beyond FcRn Binding: Functional and Kinetic Profiling of Fc-Engineered Antibody Recycling
RoukenBio
De-Risking the TCE Development Journey
RoukenBio
IndEx-2: An Inducible Cell Line Platform to Evaluate the Impact of Target Antigen Density on Immunotherapeutics
Ruhr University Bochum
Predicting the Dynamic Viscosity of High-Concentration Protein Solutions with Martini 3
Samplix ApS
Xdrop®: High-Throughput Screening in Antibody Discovery
Sanofi
A Computational Design Strategy for Biologics Engineering
Sanofi
Defeating Albumin's Limits Using Novel pH-Dependent FcRn-Binding NANOBODY® Clones: Dual FcRn-Albumin Binding Redefines NANOBODY® Half-Life
Sartorius Stedim Cellca GmbH
Next Generation Bioproduction: A Novel Engineered CHO Host for Optimized Performance in Fed-Batch and Perfusion
SCIEX
Enhancing Protein Purity Analysis Using CE-SDS with Native Fluorescence Detection
SPECIFICA, an IQVIA business
Advancing Antibody Developability Assessment: Integrating Gen3 Discovery with Orthogonal Polyreactivity Screening Approaches
Spheryx, Inc.
Total Holographic Characterization Reveals Protein Aggregates Hiding in Silicone Oil
Strike Pharma AB
Targeted LNPs made simple: An affinity-based platform for efficient CAR-M therapeutics
SunBio, Inc.
Sustained Uric Acid-Lowering Activity of CanopyPEG-Uricase Compared with Conventional mPEG-Uricase Following Repeated Administration
Tacalyx GmbH
Generation of High-Affinity Monoclonal Antibodies Targeting Tumor-Associated Carbohydrate Antigens (TACAs): Two Successful Case Studies
Target Link Therapeutics
TLT-001: Preclinical Development of a CDH17-Targeted Antibody-Drug Conjugate and Validation of Target-Specific Anticancer Efficacy
T-Cypher Bio
Novel TCR Discovery Platform Driving Bispecific T Cell Engagers Against Highly Abundant Solid Tumour Targets
Technical University of Denmark
Specificity-Driven Protein Binder Design with Odin-Multi
Technische Universität Braunschweig
Detection of Bacterial Potato Pathogens with Antibody Phage Display-Selected Antibodies
Technische Universität Darmstadt
A Selectively Activated D-aa Specific Protease to Enable Selective Drug Release in the TME
Technische Universität Darmstadt
Antibody-Degrader-Conjugates: Overcoming Biochemical and Biophysical Hurdles
Technische Universität Darmstadt
Bispecific GM-CSF Mimetics Resistant to Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Patient-Derived Anti-GM-CSF Autoantibody Responses
Technische Universität Darmstadt
Development of a Recombinant, Epitope-Diverse Human IgG Fc Detection Platform
Technische Universität Darmstadt
Discovery of TCRm-Antibodies Targeting PRAME[245-433] from a Chicken scFv Library
Technische Universität Darmstadt
Distinct Contributions of Non-Canonical Disulfide Bonds to Stability and Conformational Dynamics of VHHs
Technische Universität Darmstadt
Engineering a Tumor-Targeted Attenuated IL-12 Immunocytokine with ADCC-Dependent Granzyme B–Mediated Activation and pH-Driven Developability Optimization
Technische Universität Darmstadt
Engineering Magrolimab for Conditional and Tumor-Selective CD47 Targeting
Technische Universität Darmstadt
From Monoclonal to Bispecific: Leveraging Chicken Antibody Repertoires and Human Common Light Chain Strategy for Next-Generation Immune Cell Engagers
Technische Universität Darmstadt
Isolation of Disulphide-Rich Bovine Ultra long CDRH3 Domains Using Fc-Based Yeast Surface Display
Technische Universität Darmstadt
Rigidifying Bispecific sdAbs: Tuning IL-21 Mimetic Agonism by Paratope Geometry
Technische Universität Darmstadt
Structure-Based Prioritization of Flexible Linkers for Optimization of PROTAC Potency
Technische Universität Darmstadt
Targeted Therapeutics: Antibody functionalized LNPs for the Treatment of Ovarian Cancer
Technische Universität Darmstadt
Trispecific Antibody Drug Conjuagtes for Cancer Therapy
Teesside University, National Horizons Centre
Enhancing Viral Vector Purification Through Binder Design: Integrating In Silico and Experimental Approaches
Thermo Fisher Scientific
Automating Expi293™ PRO and ExpiCHO™ K1 PRO Expression Systems for mAb and Fc Fusion Protein Production
Thermo Fisher Scientific
Gibco™ ExpiCHO™ K1 PRO Prototype Expression System: High-Yield, Fast, and Scalable Transient Protein Expression in CHO-K1 Cells
Thermo Fisher Scientific
Redefining Clarification: Chromatographic Approaches for High-Density Bioprocessing
Tsingke Biotech
pH-Dependent Antibody Screening
Twist Bioscience
Accelerating Multispecific Antibody Discovery and Development. Robust, Easy to Access, Industry-Leading Bispecific Platform
Twist Bioscience
Antibody Discovery from Immune VHH Library Using Yeast Surface Display
Twist Bioscience
Express Screening Antibodies: SPR Data from Cell Free IgG. Expression as Few as 5 Business Days
UCB Biopharma
Enhancing Antibody Optimisation with Yeast Display, NGS, and Protein Language Models
Ulm University
2D-LC for Rapid Functional and Structural Characterization of Reversible Antibody Dimers
Unchained Labs
High-Throughput Protein Stability Screens with Aunty
Univ Estadual de Campinas
A Humanized Monoclonal Antibody Targeting IL-7Ra Shows Selective Binding and Preclinical Antileukemic Activity
Universidad Complutense de Madrid
Combining Phage and Yeast Display to Engineer Analytical Antibodies for Sesame Allergen Detection
Universidade de Lisboa
Rabbit-Derived VL Single-Domain Antibodies and In Vivo Phage Display Selection for Next-Generation ADC Development
Universidade Estadual de Campinas (UNICAMP)
Development of a Stable Cell Line Producing Anti-IL7R Antibodies by Site-Specific Integration
Universidade Estadual de Campinas (UNICAMP)
Elucidating the Anti-Leukemic Mechanism of a Novel Anti-IL7Ra Antibody in Pediatric Leukemia
Universidade Estadual de Campinas (UNICAMP)
Targeting IL7Ra with a Humanized Monoclonal Antibody: Therapeutic Potential in B- and T-Acute Lymphoblastic Leukemia
Universidade Federal do Rio Grande do Sul
Advancing Recombinant IgA Antibody Production
Universidade Federal do Rio Grande do Sul
ONCOMAB: A Platform for the Expression, Purification and Engineering of Patient-Derived Antibodies for Cancer Immunotherapy in Brazil
Università degli Studi di Siena
Development of Antibody-Antimicrobial Conjugates (AAC) to Fight Infectious Diseases
Universität Basel
From Polysorbate Degradation to Protein Quality: A Complementary Analytical Approach
Universität Leipzig
Evaluating Large Language Model Influence on Agentic Behavior in the Context of Minibinder Design
University College Dublin
Directing Generative AI Through Phage Display Screening: Evaluating a Hybrid Sequence-Structure Pipeline for GPCR Peptide Discovery
University Hospital Würzburg
Novel TNFR2 Nb-Fusion Proteins with ADCC-Inducing Capacity to Attenuate GvHD and Enhance GvL Activity
University Medical Center Hamburg-Eppendorf (UKE)
Novel Naturally Occurring Antibodies for Immunotherapy in Neuroblastoma
University of Bern
CER-21: A Next-Generation sdAb-Based Immune Checkpoint Inhibitor for Canine Cancer
University of Cambridge
Generation of Immune-Derived Naja PLA2-Neutralising Recombinant Antibodies by Phage Display
University of Cambridge
ML Design of Nanobodies Enables Affinity Maturation and α2/α3 Selectivity Switching in GABA[A] Receptors
University of Chicago
PeptiForge: Rapid, High-Quality Discovery of Peptide and Protein Binders
University of Graz
Interfering with α-Synuclein/Glycosaminoglycan Axis for Drug Development
University of Graz
Modulation of Cellular Immunity by the Potent Natural Antioxidant Astaxanthin via Protein Interactions
University of Huddersfield
Biophysical Profiling of Biosurfactants for Protein and Peptide Stability in Biologic Formulations
University of Manchester
Precipitate or Stabilise? How pH and Charge Control ATP and Tripolyphosphate Effects on Proteins
University of Manchester
Using Peptide Microarrays as Low Demand, High Throughput Formulation Screens
University of Michigan
Germline-Guided Redesign of Therapeutic Antibodies to Co-Optimize Developability and Affinity
University of Nottingham
Next-Generation Phage Display for the Identification of Novel Glycosaminoglycan Antibodies
University of Strathclyde
Understanding the Stabilization Effect of Excipients on Monoclonal Antibodies Through Integrated Experimental and Molecular Dynamics Studies
University of Stuttgart
Conditionally Active T-Cell Engagers for Tumor Therapy
University of Stuttgart
Novel Antibodies Targeting CCR9 for Cancer and Inflammatory Diseases
University of Stuttgart
Novel Antibodies Targeting the Human Cytomegalovirus (HCMV) Immune Evasins gp34 and gp68
University of the Basque Country
A New Strategy of IgG Engineering to Improve Tumor Penetrability
University of the Basque Country
Fc Heterodimerization via Asymmetric ß-Strand Redistribution
University of Victoria
Cell-Free Production and Evaluation of Antimicrobial Peptides
University of Washington
Development of Antibody Fragments as Medical Countermeasures to Reverse Drug-Induced Toxicity
Uppsala University
Affinity-Bound Antibody LNPs Enable Targeted Delivery of mRNA to T Cells In Vivo
Vanderbilt University
Adapter Proteins Enable Polytypic Delivery and Neutralizing Antisera Against Alphaviruses in Mice
Vect-Horus
Distinct Geometries, Comparable Interfaces: Binding Modes and Thermodynamic Implications in Conventional and Single Domain Antibodies
Vect-Horus
Optimization of Liquid Chromatography – Mass Spectrometry Analysis for Stability Study and Quantification of Protein Oligonucleotide Conjugates
VERAXA Biotech GmbH
A Conditionally Active T Cell Engager Platform Enabled by Split-CD3 Engineering
Veraxa Biotech GmbH
An Avidity-Driven, Bispecific ADC with Superior Tumor Selectivity Enables PDB Payloads to Treat Solid Tumors
ViSync
Beyond the Freezer: Unlocking Stable and Scalable Viral Biologics
VRG Therapeutics
AI-MPRO: Tackling Challenging Targets with De Novo Miniproteins
Vysens B.V.
Multipurpose Cell Avidity Measurements Using the CellVysion SPR Imaging Platform
Vysens B.V.
Multi-Specific Engagement Studies with World’s First Cell Avidity SPR Imaging Platform: The CellVysion
Waters Corporation
Breaking the Barriers to Antibody-Oligonucleotide Conjugate (AOC) Site Conjugation Determination and Oligo-Peptide Conjugates by LC-MS
Waters Corporation
Characterization of GLP-1 Oligomers and Higher-Order Structures Following Recent Regulatory Changes
Waters Corporation
Determining HMWS in Cell Culture Using a Simplified 2D Protein A Affinity Size Exclusion Chromatography Method
Wroclaw Medical University
Structure-Guided Design and Biophysical Evaluation of Peptides Targeting the CD47–SIRPα Interaction
WuXi Biologics
Mechanism-Guided In Vitro Characterization of Antibody-Drug Conjugates for Candidate Optimization and Differentiation
WuXi Biologics
MOA-Guided In Vivo Pharmacology Characterization of T Cell Engagers Using Complementary NHP and Murine Models to Support Translational Assessment
WuXi XDC
Accelerating Next-Generation Targeted Conjugates Through Integrated Discovery
Yokohama City University
MoHuTS: Multi-Objective Tree Search for Antibody Humanization
YUMAB GmbH
Accelerating Antibody Discovery with Full-Length IgG Display on CHO Cells
YUMAB GmbH
De-Risking TCRm Discovery and Accelerating Specificity Screening with pHLA Libraries
Zag Bio
A Fully Regenerable SPR Platform for High-Throughput Mapping of Protein-Protein Interfaces Without Purification of Ligand Variants